Solid Biosciences (SLDB) EPS (Basic) Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.28% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -2.92% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 58.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 45.92% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 30.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.37% |
| Dec 31, 2025 | 7.97% |
| Sep 30, 2025 | 43.84% |
| Jun 30, 2025 | 49.85% |
| Mar 31, 2025 | 44.06% |
| Dec 31, 2024 | 25.43% |
| Sep 30, 2024 | 30.95% |
| Jun 30, 2024 | -53.09% |
| Mar 31, 2024 | -49.90% |
| Dec 31, 2023 | 65.38% |
| Sep 30, 2023 | -33.63% |
| Jun 30, 2023 | -47.44% |
| Mar 31, 2023 | -40.10% |
| Dec 31, 2022 | -0.50% |
| Sep 30, 2022 | -59.33% |
| Jun 30, 2022 | -63.64% |
| Mar 31, 2022 | -58.27% |
| Dec 31, 2021 | -57.47% |
| Sep 30, 2021 | -63.41% |
| Jun 30, 2021 | 31.11% |
| Mar 31, 2021 | 29.40% |
| Dec 31, 2020 | -206.18% |
| Sep 30, 2020 | 17.72% |
| Jun 30, 2020 | 16.08% |
| Mar 31, 2020 | -282.59% |